Cargando…
Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer’s Disease
Certain endogenous bile acids have been proposed as potential therapies for ameliorating Alzheimer’s disease (AD) but their role, if any, in the pathophysiology of this disease is not currently known. Given recent evidence of bile acids having protective and anti-inflammatory effects on the brain, i...
Autores principales: | Pan, Xiaobei, Elliott, Christopher T., McGuinness, Bernadette, Passmore, Peter, Kehoe, Patrick G., Hölscher, Christian, McClean, Paula L., Graham, Stewart F., Green, Brian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487999/ https://www.ncbi.nlm.nih.gov/pubmed/28629125 http://dx.doi.org/10.3390/metabo7020028 |
Ejemplares similares
-
Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer’s Disease (AD) Pathology Than in Severe AD Pathology
por: Nasaruddin, Muhammad L., et al.
Publicado: (2018) -
Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s Disease
por: Graham, Stewart F., et al.
Publicado: (2015) -
Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism
por: Akyol, Sumeyya, et al.
Publicado: (2021) -
Diet and Inflammation in Cognitive Ageing and Alzheimer’s Disease
por: McGrattan, Andrea M., et al.
Publicado: (2019) -
Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition
por: Denver, Paul, et al.
Publicado: (2018)